More
    Guided Solutions - Connecting Talent With Innovation/div>

    E2 raises $80M Series C for Hēlo thrombectomy system

    Endovascular Engineering (E2) announced that it raised $80 million in an oversubscribed Series C financing round. Gilde Healthcare and Norwest co-led the latest financing for...

    Route 92 Medical brings in $50M growth financing

    Route 92 Medical announced that it secured $50 million in growth financing to support its neurovascular intervention offerings. New investor Sectoral Asset Management joined lead...

    Beacon Biosignals upsizes Series B to $97M

    Beacon Biosignals announced that it extended its Series B financing to bring the round to $97 million. In November 2025, the Boston-based company announced that...

    neuroClues closes €10M Series A, bringing total funding to €25M

    neuroClues, a MedTech company developing quantitative tools for neurological assessment, announced the close of a €10 million Series A financing round. The investment brings the...

    Lifebloom secures €8M for exoskeleton walking therapy

    French medtech innovator Lifebloom has successfully closed an €8 million funding round, injecting significant capital to advance its robotic exoskeleton therapy for mobility restoration....

    HEPTA Medical closes a €10M oversubscribed Series A

    HEPTA MEDICAL, a medical technology company developing a minimally invasive treatment for early-stage lung cancer, announced the closing of its €10 million oversubscribed Series...

    Mediwhale secures $13.1M in Series C funding, preparing for IPO

    Medical AI company Mediwhale said it completed a 20 billion won ($13.1 million) Series C funding round. Premier Partners led the investment, with KB Investment,...

    StairMed raises $73М to advance BMI and DBS system development

    China’s StairMed Technology has raised RMB 500 million ($72.7m) to advance its brain-machine interface (BMI) and deep-brain stimulation (DBS) technologies to advance treatment options...

    Lucida Medical raises £8.7M to power ‘same day’ cancer diagnosis

    IW Capital has invested in Lucida Medical, a UK-based healthtech company using AI to help clinicians diagnose prostate cancer from MRI scans faster and...

    Latest articles